patented drugs

1:48PM
Printer-friendly version
Pandemic showed that Canada needs a thriving biopharmaceutical industry

Government policies and regulations have created an environment hostile to research and innovation.


12:02PM
Printer-friendly version
Proposed ‘drug price’ changes threaten access for Canadian patients

Advanced clinical trials in Canada, which were consistent between 2015 and 2019, decreased by 26 per cent in 2020.


10:22AM
Printer-friendly version
Trump executive order may limit access to prescription drugs in Canada

Drug manufacturers may forgo sales in Canada to increase average reference prices.


7:40PM
Printer-friendly version
Ottawa’s changes to drug-pricing will deny some Canadians potentially lifesaving drugs

Forcing manufacturers of high-cost drugs to reduce their prices by up to 80 per cent is unsustainable.


1:56PM
Printer-friendly version

Pharmaceutical manufacturers take on a significant investment risk to develop new drugs.


2:36PM
Printer-friendly version
The opposition of the two U.S. presidential candidates to the Trans-Pacific Partnership (TPP) threatens progress on trade issues including intellectual property protection.